News
INGN
5.75
-4.17%
-0.25
What You Need To Know About The Inogen, Inc. (NASDAQ:INGN) Analyst Downgrade Today
Simply Wall St · 4h ago
Inogen price target lowered to $9.50 from $12 at Freedom Broker
TipRanks · 1d ago
Weekly Report: what happened at INGN last week (1102-1106)?
Weekly Report · 3d ago
Inogen Announces Leadership Transition and Cost-Reduction Program
TipRanks · 6d ago
Inogen appoints COO Andy Reding as new CEO
Seeking Alpha · 6d ago
Inogen announces leadership transition
TipRanks · 6d ago
Inogen Appoints COO Andy Reding As President, CEO, Succeeding Kevin Smith
Benzinga · 6d ago
*Inogen: Chief Operating Officer Andy Reding Appointed Pres and Chief Executive Officer >INGN
Dow Jones · 6d ago
Inogen Announces Leadership Transition
Barchart · 6d ago
Weekly Report: what happened at INGN last week (1026-1030)?
Weekly Report · 11/02 09:13
Weekly Report: what happened at INGN last week (1019-1023)?
Weekly Report · 10/26 09:13
Inogen: Cheap Enough To Take A Chance On
Seeking Alpha · 10/20 21:51
Weekly Report: what happened at INGN last week (1012-1016)?
Weekly Report · 10/19 09:13
Press Release: Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026
Dow Jones · 10/15 17:01
Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026
Barchart · 10/15 12:00
What Inogen Investors Missed Before The Fall
Simply Wall St · 10/14 12:22
Weekly Report: what happened at INGN last week (1005-1009)?
Weekly Report · 10/12 09:14
Weekly Report: what happened at INGN last week (0928-1002)?
Weekly Report · 10/05 09:14
Inogen: Selling Rental Is A Start, Continued Work To Be Done
Seeking Alpha · 10/01 20:06
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 10/01 17:06
More
Webull provides a variety of real-time INGN stock news. You can receive the latest news about Inogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About INGN
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.